The possible relationship between onco/suppressor gene expression and carcinogen exposure In Vivo: Evaluation of a potential biomarker in preventive and predictive medicine

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2109-2116

  Ember, István ^a   Gyöngyi, Zoltán ^a   Kiss, István ^a   Ghodratollah, Nowrasteh ^a   Arany, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Carcinogenesis; Oncogenes; Preventive medicine; Tumor suppressor genes

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BIOLOGICAL MARKER; CARCINOGEN; DIMETHYLHYDRAZINE; METHYLNITROSOUREA; ONCOPROTEIN; PROTEIN P53; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER PREVENTION; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENE EXPRESSION; GENETIC SCREENING; HIGH RISK POPULATION; MALE; NONHUMAN; ONCOGENE; ONTOGENY; PATHOLOGICAL ANATOMY; PREDICTION; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT; RNA ANALYSIS;

CARCINOGENS; ENVIRONMENTAL EXPOSURE; GENES, TUMOR SUPPRESSOR; HUMANS; ONCOGENES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036331903     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Mouse liver carcinogenesis
2. Multistage carcinogenesis: Population-based model for colon cancer. Carcinogenesis
3. Studies on acute myelomonocytic leukemia in LBF I rats
4. Investigation of oncogene action in a metastatic rat model
5. Identification of chromosome 18q gene altered in colorectal cancers
6. Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation
7. Embryogenesis and carcinogenesis: Order and disorder
8. Differential expression of c-myc family genes during murine development
9. Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development
10. Differential expression of the ras gene family in mice
11. Elevated levels of c-jun and c-fos transcripts in the aged rat liver
12. Rapid and preferential activation of the c-jun gene during the mammalian UV response
13. Alterations in mRNA stability during rat liver regeneration
14. Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA
15. DNA methylation and oncogene expression in methapyrilene-induced rat liver tumors and in treated hepatocytes in culture
16. Proto-oncogene activation during chemically induced hepatocarcinogenesis in rodents
17. Molecular genetic analysis of preneoplastic and neoplastic liver lesions in the mouse
18. c-fos mRNA, Fos and Fos-related antigen induction by hypertonic saline and stress
19. Expression of the proto-oncogene c-fos following electrical kindling in the rat
20. Distribution, covalent binding and DNA adduct formation of 7,12 dimethylbenz[α]anthracene in SENCAR and Balb/c mice following topical and oral administration
21. Chromosome marker and enhanced expression of c-Ha-ras in a DMBA-induced erythroleukemia cell line (D5AI)
22. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia
23. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[α]anthracene-induced rat
24. N-ras mutation in 7,12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in Long Evans rats
25. Specific N-ras mutation in bone marrow within 48 h of 7,12-dimethylbenz[α]anthracene treatment in Huggins-Sugiyama rat leukemogenesis
26. Clinical implications of the p 53 tumor suppressor gene
27. Expression of p53 mutant protein/s in diethylnitrosamine-induced foci of enzyme-altered hepatocytes in male Fischer-344 rats
28. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands
29. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3′-azido-2′,3′-dideoxythymidine
30. Investigation of c-myc oncogene amplification in colorectal cancer
31. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma
32. The usefulness of in vivo gene expression investigation from peripheral white blood cells: A preliminary study
33. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
34. Gene expression changes as potential biomarkers of tumor-bearing status in human
35. Expression of c-erb-B proto-oncogene during dimethylbenz(α)antracene-induced tumorigenesis in hamster cheek pouch
36. The immediate-early gene c-fos and c-jun are differently expressed in the rat adrenal gland after capsaicin treatment
37. Activation of cellular oncogenes in human thyroid carcinomas
38. Enhanched expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/loTI/2 C18 mouse embryo fibroblasts
39. The role of hyperplastic nodules in dichloroacetic-acid-induced hepatocarcino-genesis in B 6C3F1 male mice
40. The potential usefulness markers in risk assesement
41. Effect of 7,12-dimethyl- benz[α]antracene on onco/suppressor gene action in vivo, short term experiment
42. Short-term effects of 1-nitropyrene on chromasomes and on oncogene/suppressor gene expression in vivo
43. Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumor suppressor genes
44. Early effect of cyclophosphamide on oncogene expression, in vivo
45. Comparative study on genotoxic and carcinogenic effect of different cytostatic protocols I in vivo investigation in CBA/Ca mice
46. Early effect of cyclosporin A in vivo oncogene expression
47. Effect of different cytostatic protocols on oncogene expression and amplification in CBA/Ca mice
48. In vivo effects of COPP protocol on onco and suppressor gene expression in a "follow-up study"
49. Different H-2 complexes given altered susceptibility for chemical carcinogen-induced oncogene expression
50. In vivo effects of CHOP protocol on onco and expression in "follow-up study"
51. Effects of ABVD therapeutic protocol on oncogene and tumor suppressor gene expression in CBA/Ca mice
52. Early oncogene action as a new biomarkers of chemical carcinogene exposition
53. Gene-environment interaction (A challenges for future)
54. Genetic polymorphisms of CYPIAI, CYP2EI, and GSTMI genes: Susceptibility to colon cancer
55. Expression of myc, fos, and Ha-ras in the livers of furan-treated F 344 rats and B6C3F1 mice
56. Immediate early gene induction after neonatal hypoxia-ischemia
57. Different H-2 complexes given altered susceptibility for chemical carcinogen induced oncogene expression
58. A molecular approach to leukemogenesis: Mouse lymphomas contain an activated c-ras oncogene
59. Oncogenes and anti-oncogenes the molecular basis of tumor behaviour
60. Transplantation of chemically-induced mouse leukemias into F344 newborn rats
61. Effect of different cytostatic protocol on N-ras and c-myc oncogene action
62. Comparative study of two different oncogenes in chemically-induced and transplanted rat myelomonotycic leukemia
63. Cadmium, gene regulation, and cellular signalling in mammalian cells
64. Detection elevated oncogene expression in brain tumors and their macroscopically healthy surrounding tissues
65. Onco and suppressor gene expression as a biomarker for ethylene oxide exposure
66. Molecular and genetic analysis reveal chromosomal deletions genetic alterations and expression of oncogenes/tumor suppressor genes in the progression of head and neck cancer
67. Genomic abnormalities in hepatocarcinogenesis implications for a chemopreventive strategy
68. Proto-oncogene activation during chemically induced hepatocarcinogenesis, in rodents
69. Molecular epidemiology and prevention of cancer
70. Biomarkers of gene expression growth factors and oncoprotein
71. Precancer biology: Importance and possible prevention
72. Induction and time course of DNA single-strand breaks in lymphocytes from patients treated with dacarbazine